Lallemand to bring probiotic for women’s health to EU markets

By Will Chu

- Last updated on GMT


Related tags Lallemand Proge Farm Probiotic

Lallemand Health Solutions and Proge Farm finalise a licensing deal for the commercialisation of L. plantarum P17630 (Proge P17630), a probiotic strain that addresses a number of women’s health conditions.

The licensing agreement is set to apply to countries such as France and Czechia as well as the Asia and the Americas territories and commercialises a strain, which addresses vaginal health, specifically recurrent vulvovaginal candidiasis.

While its oral formulation is now licensed to Lallemand Health Solutions, Proge Farm also proposes L. plantarum P17630​ (Proge 17630) as the active ingredient of a remedy for vaginal use in softgel capsules.

“Women’s health is gaining more importance in the probiotics market as consumers are increasingly looking for natural ways to take care of their intimate health,”​ says Isabelle Champié, vice-president sales and marketing at Lallemand Health Solutions.

“Furthermore, with this specific strain, it will be even easier to do so with one daily dose taken orally (5bn Colony Forming Units per day (CFU/day).”

Probiotics for women’s health

According to Lumina Intelligence, women are turning to probiotics as a natural alternative to conventional solutions, especially where reoccurring pains and infections occur, such as those linked to vaginal health.

Further analysis of the 252 probiotic products for women that included supplements, juices and cosmetics in 20 researched countries, found L. Acidophilus​, L. Rhamnosus​ and L. Plantarum​ amongst the top ten most popular species.

Along with Lallemand, firms that work with various strains of L. Plantarum​ include Sweden-based Probi, DuPont Nutrition & Biosciences and AB biotics.

L. plantarum P17630​ (Proge 17630), is isolated from a healthy vaginal flora, playing a role in supporting and maintaining an equilibrium of a normal vaginal microflora.

The strain has a number of benefits to vaginal health, from helping maintain proper vaginal balance to being used in combination with conventional treatments for candidiasis (anti-fungal).

As a result, women saw an improvement in candidiasis with a decrease in symptoms including less swelling, redness, burning or itching. The strain can also help reduce the risk of recurrence of candidiasis.

Proge Farm products

Founded in Italy in 1992, Proge Farm develops selected probiotic strains for the gastrointestinal, gynaecological and dermatological therapeutic areas.

The firm currently produces such products as Endolac, a probiotic remedy containing L. acidophilus P-18806, Lactobacillus delbrueckii P-18805​ and Streptococcus thermophilus P-18807​, for intestinal complaints such as diarrhoea, nonspecific enteritis and colitis.

“We are proud of this significant licensing commercialisation agreement with Lallemand Health Solutions,” ​adds Giancarla Dondi, owner and chief executive officer at Proge Farm.

“They will have the ability to broadly disseminate our strain L. plantarum P17630 (Proge 17630); meaning more women will benefit from its compelling effects.”

Related news

Show more

Related products

show more

HRB probiotics in the HMO era

HRB probiotics in the HMO era

Content provided by Morinaga Milk Industry Co., Ltd. | 29-Apr-2024 | White Paper

Discover the science behind human-residential bifidobacteria (HRB) probiotics and their superior benefits for infants.

Women's Health Before, During & Beyond Menopause

Women's Health Before, During & Beyond Menopause

Content provided by Akay Bioactives | 26-Apr-2024 | White Paper

Discover the science of FenuSmart®, a unique fenugreek seed extract that merges ancient wisdom with modern clinical research to support women's health...

Related suppliers

Follow us


View more